Jazz Pharmaceuticals plc (JAZZ) and Intec Pharma Ltd. (NASDAQ:NTEC) Comparing side by side

Both Jazz Pharmaceuticals plc (NASDAQ:JAZZ) and Intec Pharma Ltd. (NASDAQ:NTEC) are each other’s competitor in the Biotechnology industry. Thus the contrast of their profitability, analyst recommendations, risk, dividends, institutional ownership, earnings and valuation.

Valuation Earnings

Table 1 highlights Jazz Pharmaceuticals plc and Intec Pharma Ltd.’s gross revenue, earnings per share and valuation.

Profitability

Table 2 shows the return on equity, net margins and return on assets of the two firms.

Analyst Ratings

The Recommendations and Ratings for Jazz Pharmaceuticals plc and Intec Pharma Ltd. are featured in the next table.

$185 is Jazz Pharmaceuticals plc’s consensus target price while its potential upside is 47.65%.

Institutional and Insider Ownership

Roughly 95.9% of Jazz Pharmaceuticals plc shares are owned by institutional investors while 40.62% of Intec Pharma Ltd. are owned by institutional investors. Jazz Pharmaceuticals plc’s share owned by

... read more at: https://hinewulm.com/2019/02/08/jazz-pharmaceuticals-plc-jazz-and-intec-pharma-ltd-nasdaqntec-comparing-side-by-side/

by

Leave a Reply